Publications by authors named "Andre Willasch"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

200

Total Likes

11

Extended Reach

27,152

Social Features

4
C
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP.
Andre Manfred Willasch, Claire Horgan, Christina Peters, Adriana Balduzzi, Jean-Hugues Dalle

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
Julia Fekadu-Siebald, Emilia Salzmann-Manrique, Jan Robert Heusel, Andre Willasch, Fabian Hauck

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency.
Sophia Trombello, Andrea Jarisch, Andre Willasch, Eva Rettinger, Julia Fekadu-Siebald

Front Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Andrea Jarisch, Emilia Salzmann-Manrique, Jan Soerensen, Gudrun Sach, Eva Rettinger, Andre Willasch

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation.
Laura M Moser, Julia Fekadu, André Willasch, Eva Rettinger, Jan Sörensen

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
Masato Ogishi, Andrés Augusto Arias, Rui Yang, Ji Eun Han, Peng Zhang, Andre M Willasch

J Exp Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.
Andre Manfred Willasch, Christina Peters, Petr Sedláček, Jean-Hugues Dalle, Vassiliki Kitra-Roussou

Bone Marrow Transplant· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Marianne Ifversen, Roland Meisel, Petr Sedlacek, Krzysztof Kalwak, Luisa Sisinni, Andre Manfred Willasch

Front Pediatr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO incompatibile graft management in pediatric transplantation.
Adriana Balduzzi, Halvard Bönig, Andrea Jarisch, Tiago Nava, Marc Ansari, André Willasch

Bone Marrow Transplant· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: ABO incompatibile graft management in pediatric transplantation.
Adriana Balduzzi, Halvard Bönig, Andrea Jarisch, Tiago Nava, Marc Ansari, André Willasch

Bone Marrow Transplant· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.
Andre Manfred Willasch, Christina Peters, Petr Sedláček, Jean-Hugues Dalle, Vassiliki Kitra-Roussou

Bone Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Tiago Nava, Marc Ansari, Jean-Hugues Dalle, Christina Diaz de Heredia, Tayfun Güngör, Andre Willasch

Bone Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Tiago Nava, Marc Ansari, Jean-Hugues Dalle, Christina Diaz de Heredia, Tayfun Güngör, Andre Willasch

Bone Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance to Bone Morbidity in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Michaela Kuhlen, Marina Kunstreich, Riitta Niinimäki, Desiree Dunstheimer, Anita Lawitschka, André Willasch

Biol Blood Marrow Transplant· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.
Peter Bader, Emilia Salzmann-Manrique, Adriana Balduzzi, Jean-Hugues Dalle, Ann E Woolfrey, Andre M Willasch

Blood Adv· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.
Herbert Pichler, Anita Lawitschka, Evgenia Glogova, Andre M Willasch, Irene von Luettichau

Am J Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions.
Michael Merker, Emilia Salzmann-Manrique, Verena Katzki, Sabine Huenecke, Melanie Bremm, Andre Willasch

Biol Blood Marrow Transplant· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AlloHSCT in paediatric ALL and AML in complete remission: improvement over time impacted by accreditation?
Shahrzad Bakhtiar, Emilia Salzmann-Manrique, Martin Hutter, Thomas Krenn, Matthias Duerken, Andre Manfred Willasch

Bone Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients.
Nora Doberschuetz, Jan Soerensen, Halvard Bonig, Andre Willasch, Eva Rettinger

Transfusion· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
Michael Merker, Michael Torsten Meister, Eva Rettinger, Andrea Jarisch, Jan Soerensen, Andre Willasch

Bone Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial.
Michaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, Jacek Wachowiak, Isaac Yaniv

Br J Haematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation.
Eva Rettinger, Michael Merker, Emilia Salzmann-Manrique, Hermann Kreyenberg, Thomas Krenn, Andre Willasch

Biol Blood Marrow Transplant· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study.
Giovanna Lucchini, Andre Manfred Willasch, Julia Daniel, Jan Soerensen, Andrea Jarisch

Pediatr Transplant· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy.
Eva Rettinger, Sabine Huenecke, Halvard Bonig, Michael Merker, Andrea Jarisch, Andre Willasch

Haematologica· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis